loading
Precedente Chiudi:
$2.845
Aprire:
$2.78
Volume 24 ore:
437.59K
Relative Volume:
0.18
Capitalizzazione di mercato:
$492.92M
Reddito:
$25.55M
Utile/perdita netta:
$-341.97M
Rapporto P/E:
-1.0286
EPS:
-2.8
Flusso di cassa netto:
$-304.44M
1 W Prestazione:
+2.14%
1M Prestazione:
-7.72%
6M Prestazione:
-39.58%
1 anno Prestazione:
-58.88%
Intervallo 1D:
Value
$2.75
$2.90
Intervallo di 1 settimana:
Value
$2.75
$3.16
Portata 52W:
Value
$1.775
$10.72

Relay Therapeutics Inc Stock (RLAY) Company Profile

Name
Nome
Relay Therapeutics Inc
Name
Telefono
617-370-8837
Name
Indirizzo
399 BINNEY STREET, CAMBRIDGE
Name
Dipendente
259
Name
Cinguettio
Name
Prossima data di guadagno
2025-02-21
Name
Ultimi documenti SEC
Name
RLAY's Discussions on Twitter

Confronta RLAY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RLAY
Relay Therapeutics Inc
2.875 478.33M 25.55M -341.97M -304.44M -2.80
Biotechnology icon
ONC
Beigene Ltd Adr
242.08 24.41B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
436.46 111.55B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.31 42.47M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
588.93 63.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
74.87 5.92B 0 -153.72M -103.81M -2.00

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-17 Iniziato Wells Fargo Equal Weight
2024-09-10 Ripresa Goldman Buy
2024-09-10 Aggiornamento Jefferies Hold → Buy
2024-09-10 Downgrade Oppenheimer Outperform → Perform
2024-05-10 Aggiornamento Barclays Equal Weight → Overweight
2023-04-20 Aggiornamento Jefferies Underperform → Hold
2023-04-19 Aggiornamento Raymond James Outperform → Strong Buy
2023-04-13 Iniziato Raymond James Outperform
2023-02-03 Iniziato Oppenheimer Outperform
2022-09-30 Iniziato Barclays Equal Weight
2022-09-02 Iniziato Stifel Buy
2022-06-06 Iniziato Jefferies Underperform
2022-02-01 Iniziato Berenberg Buy
2021-07-21 Iniziato BofA Securities Buy
2020-12-15 Reiterato H.C. Wainwright Buy
2020-12-08 Iniziato JMP Securities Mkt Outperform
2020-11-05 Iniziato H.C. Wainwright Buy
2020-08-10 Iniziato Cowen Outperform
2020-08-10 Iniziato Goldman Buy
2020-08-10 Iniziato Guggenheim Buy
2020-08-10 Iniziato JP Morgan Neutral
Mostra tutto

Relay Therapeutics Inc Borsa (RLAY) Ultime notizie

pulisher
May 22, 2025

Northern Trust Corp Buys 231,713 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 22, 2025
pulisher
May 21, 2025

BNP Paribas Financial Markets Invests $987,000 in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 21, 2025
pulisher
May 17, 2025

Stifel Financial Corp Makes New Investment in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 17, 2025
pulisher
May 16, 2025

Layoff Tracker: Allogene Cuts 28% of Staff to Extend Runway, Focus on Clinical Programs - BioSpace

May 16, 2025
pulisher
May 16, 2025

Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

May 16, 2025
pulisher
May 14, 2025

Transcript : Relay Therapeutics, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 03 - marketscreener.com

May 14, 2025
pulisher
May 13, 2025

Relay Therapeutics, Inc. (RLAY): One of the Best Low Priced Biotech Stocks to Buy Now - Yahoo Finance

May 13, 2025
pulisher
May 12, 2025

10 Best Low-Priced Biotech Stocks to Buy Now - Insider Monkey

May 12, 2025
pulisher
May 12, 2025

HC Wainwright Issues Optimistic Forecast for RLAY Earnings - Defense World

May 12, 2025
pulisher
May 11, 2025

Relay Therapeutics, Inc. (RLAY): A Bull Case Theory - MSN

May 11, 2025
pulisher
May 11, 2025

89,949 Shares in Relay Therapeutics, Inc. (NASDAQ:RLAY) Purchased by First Trust Advisors LP - Defense World

May 11, 2025
pulisher
May 10, 2025

Dimensional Fund Advisors LP Grows Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 10, 2025
pulisher
May 09, 2025

Q2 EPS Estimate for Relay Therapeutics Lowered by Analyst - Defense World

May 09, 2025
pulisher
May 08, 2025

Relay Therapeutics to Participate in Two Upcoming Investor Conferences - The Manila Times

May 08, 2025
pulisher
May 08, 2025

Hsbc Holdings PLC Has $458,000 Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - The AM Reporter

May 08, 2025
pulisher
May 08, 2025

MetLife Investment Management LLC Grows Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 08, 2025
pulisher
May 07, 2025

Guggenheim Lowers Price Target for Relay Therapeutics (RLAY) to $10.00 | RLAY Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Relay Therapeutics (RLAY) Stock Target Reduced Amid Strategic Changes and Progress | RLAY Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Marshall Wace LLP Lowers Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 07, 2025
pulisher
May 07, 2025

Raymond James Financial Inc. Takes $779,000 Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 07, 2025
pulisher
May 07, 2025

Wells Fargo & Company MN Decreases Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 07, 2025
pulisher
May 06, 2025

Relay Therapeutics Inc (RLAY) Q1 2025 Earnings: EPS Loss of $0.4 - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Relay Therapeutics (RLAY) Reports Decline in Q1 Revenue | RLAY S - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Relay Therapeutics Extends Cash Runway and Advances Clinical Trials - TipRanks

May 06, 2025
pulisher
May 05, 2025

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates | RLAY Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Relay Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 05, 2025
pulisher
May 05, 2025

Relay Therapeutics, Inc. SEC 10-Q Report - TradingView

May 05, 2025
pulisher
May 05, 2025

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates - The Manila Times

May 05, 2025
pulisher
May 05, 2025

Relay Therapeutics Extends Cash Runway into 2029 Amid Clinical Trial Advancements - Nasdaq

May 05, 2025
pulisher
May 05, 2025

Barclays PLC Has $1.29 Million Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 05, 2025
pulisher
May 04, 2025

Invesco Ltd. Acquires 5,261 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 04, 2025
pulisher
May 02, 2025

There Is A Lot Of Upside Potential For Relay Therapeutics Inc(NASDAQ: RLAY) - Stocksregister

May 02, 2025
pulisher
May 01, 2025

why Relay Therapeutics Inc [RLAY] is a Good Choice for Investors After New Price Target of $17.40 - dbtnews.com

May 01, 2025
pulisher
May 01, 2025

Relay Therapeutics executive sells $36,540 in stock By Investing.com - Investing.com Nigeria

May 01, 2025
pulisher
May 01, 2025

Relay Therapeutics executive sells $36,540 in stock - Investing.com Australia

May 01, 2025
pulisher
May 01, 2025

LPL Financial LLC Sells 6,564 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

May 01, 2025
pulisher
May 01, 2025

Relay Therapeutics president sells $95,381 in stock By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

Relay Therapeutics chief legal officer sells $44,040 in stock By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

Relay Therapeutics CFO sells shares worth $44,246 By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
Apr 30, 2025

Relay Therapeutics Inc Stock: Executives Sell Shares Amid Mixed Signals - sharewise

Apr 30, 2025
pulisher
Apr 30, 2025

Relay Therapeutics president sells $95,381 in stock - Investing.com Australia

Apr 30, 2025
pulisher
Apr 30, 2025

Relay Therapeutics CFO sells shares worth $44,246 - Investing.com Australia

Apr 30, 2025
pulisher
Apr 30, 2025

Relay Therapeutics chief legal officer sells $44,040 in stock - Investing.com

Apr 30, 2025
pulisher
Apr 30, 2025

Relay Therapeutics Executives Sell Shares to Cover Tax Obligations and Under Trading Plan - TradingView

Apr 30, 2025
pulisher
Apr 30, 2025

Healthy Upside Potential: Relay Therapeutics Inc (RLAY) - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Trading Day Review: Relay Therapeutics Inc (RLAY) Loses Momentum, Closing at 3.10 - DWinneX

Apr 30, 2025

Relay Therapeutics Inc Azioni (RLAY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Relay Therapeutics Inc Azioni (RLAY) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Rahmer Peter
See remarks
Apr 28 '25
Sale
3.17
1,364
4,324
400,820
Catinazzo Thomas
Chief Financial Officer
Apr 30 '25
Sale
3.00
12,943
38,829
355,376
Catinazzo Thomas
Chief Financial Officer
Apr 29 '25
Sale
3.23
3,558
11,492
368,319
Catinazzo Thomas
Chief Financial Officer
Apr 28 '25
Sale
3.17
2,690
8,527
371,877
Bergstrom Donald A
President, R&D
Apr 30 '25
Sale
3.00
27,472
82,416
583,490
Bergstrom Donald A
President, R&D
Apr 28 '25
Sale
3.17
4,090
12,965
610,962
Adams Brian
Chief Legal Officer
Apr 30 '25
Sale
3.00
12,943
38,829
391,385
Adams Brian
Chief Legal Officer
Apr 28 '25
Sale
3.17
1,644
5,211
404,328
$1.16
price down icon 17.27%
$31.18
price down icon 3.94%
$578.71
price down icon 0.54%
$286.89
price down icon 0.52%
$4.10
price down icon 2.24%
$72.94
price down icon 0.11%
Capitalizzazione:     |  Volume (24 ore):